12 January 2026 - Top Stories

Recent developments in health and healthtech across Australia and beyond highlight ongoing efforts to improve patient access, data security, and innovative treatments. The Australian government is restoring ECG reimbursements for general practitioners from March 2026, reversing a previous cut that limited cardiac diagnostics in primary care. This move, supported by a $24 million fund, aims to strengthen primary care capacity and improve patient outcomes. Meanwhile, funding for early-career health researchers continues with over $10 million allocated to projects addressing neurodegeneration and women’s health, signalling a focus on long-term health challenges.

In digital health, Australian company Alcidion has secured a £20 million contract to implement its Miya platform at University Hospitals Sussex in the UK. This reflects the increasing international footprint of Australian healthtech firms and the importance of integrated digital systems for large hospital networks. Additionally, the UK’s shift in vaccine guidance, which questions previous links between vaccines and autism, underscores the ongoing battle against misinformation and its impact on public health messaging globally.

On the policy front, Australia is moving to expand PBS coverage for GLP-1 drugs like Wegovy, which are currently only subsidised for type 2 diabetes. The proposed listing aims to improve access for high-risk individuals with obesity, with negotiations on pricing underway. This follows a broader trend of making weight-loss medications more affordable and accessible, potentially transforming obesity management in Australia. Similarly, the listing of women’s health medications on PBS has already saved over $60 million in the first year, demonstrating a commitment to addressing women’s health needs through subsidised treatments.

Cybersecurity remains a concern, as Health New Zealand responded to a breach involving patient data in Northland. The organisation is providing support and working with primary care providers to fund consultations for affected patients, highlighting the need for robust data security measures in health tech. The case involving the Queensland PSR also serves as a reminder of regulatory risks, with a recent court ruling criticising a regulator’s actions as reckless and potentially opening avenues for legal challenges.

Overall, these stories reflect a health landscape focused on expanding access, leveraging technology, and navigating complex regulatory and security environments. The emphasis on affordability, innovation, and patient-centred care continues to shape health policy and practice across Australia and internationally.

• Restoration of ECG reimbursements for GPs in Australia from March 2026
• Over $10 million allocated to early-career health research projects
• Australian firm Alcidion wins a £20 million contract in the UK
• Australia moves to list Wegovy on PBS for obesity treatment
• Women’s health medications on PBS save over $60 million in nine months
• UK shifts vaccine guidance amid misinformation concerns
• Cybersecurity breach prompts support measures in New Zealand